SmithSolve

SmithSolve is a healthcare-focused communications agency that helps pharmaceutical, biotech, and medical device companies engage with multiple stakeholder groups including patients, advocates, physicians, investigators, investors, and policymakers. The firm provides strategic communications services designed to translate complex scientific information and build trust across diverse healthcare audiences.

The agency's core capabilities span corporate communications, product and pipeline communications, patient engagement and advocacy, and digital and social strategy. SmithSolve demonstrates particular expertise in rare disease communications, having partnered with organizations like Rare Disease Legislative Advocates (RDLA) to create the Fast Forward for Rare initiative, which helps patient advocates share their stories with impact.

Notable client work includes repositioning Alexion Pharmaceuticals' media narrative from orphan drug pricing criticism to innovation leadership, resulting in a seven-page Forbes profile that contributed to Alexion earning the #2 spot in Forbes' World's Most Innovative Companies rankings in 2012 and 2013. The agency emphasizes what they call a 'surround sound' approach, using multiple communications channels and methods to reach target audiences.

Choose SmithSolve when your pharmaceutical or biotech company needs to build trust and credibility around innovative therapies, particularly for rare diseases or conditions facing pricing or access challenges. The agency excels at connecting scientific innovation to human impact through patient engagement and multi-channel storytelling.

Expect a collaborative approach that emphasizes authentic patient voices and strategic media relations. The agency's understanding of regulatory constraints combined with creative communications suggests they can navigate the complex compliance requirements inherent in pharmaceutical marketing while still delivering compelling narratives.

SmithSolve operates exclusively in healthcare communications, with particular depth in the pharmaceutical and biotechnology sectors. The agency demonstrates specialized expertise in rare disease patient advocacy, orphan drug communications, and navigating the regulatory environment specific to pharmaceutical marketing and medical affairs.

Their healthcare-specific approach includes connecting companies with patient advocacy organizations, managing issues related to drug pricing and access, translating complex scientific information for diverse audiences, and developing compliant digital strategies that address medical-legal-regulatory review requirements unique to pharmaceutical communications.

The ideal SmithSolve client is a pharmaceutical or biotech company developing therapies for rare diseases or underserved patient populations that needs to build credibility beyond product efficacy. These companies typically face complex stakeholder dynamics involving patient advocates, physicians, payers, and policymakers, and benefit from communications strategies that emphasize patient impact and scientific innovation over purely commercial messaging.